Botulinum Neurotoxins and Nervous System (Record no. 30086)

MARC details
000 -LEADER
fixed length control field 02591nam a2200121Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220620s9999||||xx |||||||||||||| ||und||
245 #0 - TITLE STATEMENT
Title Botulinum Neurotoxins and Nervous System
Remainder of title Future Challenges for Novel Indications
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element botulinum toxin||limb tremors||muscle selection||biological effect||various cell types||neurotransmitter||dermatology||novel indication||botulinum neurotoxin||masticatory system||maxillofacial bone||dental occlusion||orthognathic surgery||sialorrhoea||drooling||salivary glands||swallowing||eccrine glands||onabotulinumtoxin A||incobotulinumtoxin A||botulinum neurotoxins||botulinum neurotoxin serotype A||heavy chain||botulinum neurotoxin serotype a heavy chain (BoNT/A HC)||spinal cord injury (SCI)||nerve regeneration||growth associated protein 43 (GAP-43)||superior cervical ganglion 10 (SCG10)||neuronal processes||neural regeneration||Schwann cells||glia||spinal cord||immunohistochemistry||allodynia||weight bearing||sciatic static index||walking track analysis||itch||SNARE||VAMP||mast cells||compound 48/80||chloroquine||spasticity||botulinum toxin type A||appropriate treatment||Therapeutic Index||pruritus||antipruritic||clinical||experimental||BoNT/A||astroglia||interleukins||microglia||TLR2||TLR4||Snap-23||pain||cerebral palsy||botulinum toxin A||complex regional pain syndrome||lumbar sympathetic ganglion block||chronic pelvic pain||overactive detrusor||vaginism||temporomandibular joint dislocation||lateral pterygoid muscle||botulinum toxin therapy||synaptic transmission||SNAP-25||epilepsy||Parkinson’s disease||neurotransmission blockade||electrical activity||prion disease||new indications||formulation||delivery||refractory chronic migraine||tension headache||medication overuse headache||prophylactic treatment||XEOMIN®||BTX||central neuropathic pain||spinal cord injury||post-stroke shoulder pain||mouse test||Clostridium tetani||botulinum antitoxin||food safety||abobotulinumtoxinA||upper limb spasticity||post-stroke||early use||ONTIME||clinical trial||human||urodynamics||botulinum neurotoxin-A||basal ganglia||interspecies differences in motor behavior||mouse||rat||interneurons||hand tremor||treatment||electromyography||kinematics||essential tremor||dystonic tremor||tremor||movement disorders||Botulinum toxin||upper limb biomechanics||joint biomechanics||diagnostic guidance||clinical decision support||spastic paresis||electrical stimulation||stroke management||rehabilitation||hand||n/a
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Luvisetto, Siro
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/3054">https://mdpi.com/books/pdfview/book/3054</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 20/06/2022   20/06/2022 20/06/2022 E-Books